NMR methods in fragment based drug discovery

被引:0
|
作者
Lim, Jongsoo [1 ]
机构
[1] Innovat Med Res Labs, Mol Pharmacol Team, 21 Geumhwa Ro 105 Beon Gil, Yongin 446905, Gyeonggi Do, South Korea
来源
关键词
FBDD; HTS; NMR; Fragment library quality control;
D O I
10.6564/JKMRS.2015.19.3.132
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Nuclear magnetic resonance (NMR) spectroscopy, owing to its ability to provide atomic level information on molecular structure, dynamics and interaction, has become one of the most powerful methods in early drug discovery where hit finding and hit-to-lead generation are mainly pursued. In recent years, drug discovery programs originating from the fragment-based drug discovery (FBDD) strategies have been widely incorporated into academia and industry in which a wide variety of NMR methods become an indispensable arsenal to elucidate the binding of small molecules onto bimolecular targets. In this review, I briefly describe FBDD and introduce NMR methods mainly used in FBDD campaigns of my company. In addition, quality control of fragment library and practical NMR methods in industrial aspect are discussed shortly.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 50 条
  • [41] Fragment and Protein Simulation Methods in Fragment Based Drug Design
    Klon, Anthony E.
    Konteatis, Zenon
    Meshkat, Siavash N.
    Zou, Jinming
    Reynolds, Charles H.
    DRUG DEVELOPMENT RESEARCH, 2011, 72 (02) : 130 - 137
  • [42] Ligand efficiency and fragment-based drug discovery
    Bembenek, Scott D.
    Tounge, Brett A.
    Reynolds, Chades H.
    DRUG DISCOVERY TODAY, 2009, 14 (5-6) : 278 - 283
  • [43] Fragment-based drug discovery through tethering
    Erlanson, DA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2763 - U2763
  • [44] Fragment based drug discovery - from crystal to clinic
    Williams, B.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A77 - A77
  • [45] Strategies and experiences in fragment-based drug discovery
    Hubbard, Roderick E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 510 - 510
  • [46] Advances in fragment-based drug discovery platforms
    Orita, Masaya
    Warizaya, Masaichi
    Amano, Yasushi
    Ohno, Kazuki
    Niimi, Tatsuya
    EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (11) : 1125 - 1144
  • [47] What is the future for fragment-based drug discovery?
    Keseru, Gyorgy M.
    Hann, Michael M.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (13) : 1457 - 1460
  • [48] Fragment approaches in structure-based drug discovery
    Hubbard, Roderick E.
    JOURNAL OF SYNCHROTRON RADIATION, 2008, 15 (227-230) : 227 - 230
  • [49] High throughput crystallography in fragment based drug discovery
    Vinkovic, Mladen
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2007, 63 : S13 - S13
  • [50] Is it time for biocatalysis in fragment-based drug discovery?
    Ramsden, Jeremy I.
    Cosgrove, Sebastian C.
    Turner, Nicholas J.
    CHEMICAL SCIENCE, 2020, 11 (41) : 11104 - 11112